What’s Driving Growth in the Anticoagulants Market? Insights into Key Trends and Opportunities
Updated 2025 Market Reports Released: Trends, Forecasts to 2034 – Early Purchase Your Competitive Edge Today!
How has the anticoagulants market grown in recent years?
The size of the anticoagulants market has been on a rapid rise in the past few years. The projections show that its worth will increase from $49.33 billion in 2024 to $54.39 billion in 2025, with a compound annual growth rate (CAGR) of 10.3%. Factors behind this growth trend in the historic period include factors such as increased ageing population, growing number of cardiovascular disease cases, increased awareness about the significance of using anticoagulant therapy, widened applications for anticoagulant use, and a surge in cases of venous thromboembolism (VTE) and atrial fibrillation.
How is the anticoagulants market size expected to evolve during the forecast period?
In the coming years, a swift expansion is predicted for the anticoagulants market. Its size is forecasted to escalate to $87.76 billion by 2029, exhibiting a compound annual growth rate (CAGR) of 12.7%. The growth anticipated in the forecast duration is due to factors such as diversified applications for innovative anticoagulant medications, escalating healthcare costs, the emergence of novel oral anticoagulants (NOACs) as primary treatment modes, financial aid from senior authorities for healthcare facility overhaul, and healthcare infrastructure expansion. Predominant trends projected for the forecast period encompass progressions in medical technologies and diagnostic techniques, artificial intelligence and data analytics’ inclusion in anticoagulant treatment, an increased focus on patient education and adherence programs, and the invention of reversal agents.
Get your anticoagulants market report here!
https://www.thebusinessresearchcompany.com/report/anti-static-films-global-market-report
Which key drivers are propelling the anticoagulants market’s growth?
The escalating prevalence of cardiovascular conditions is a primary variable propelling the anticoagulants market’s expansion in the upcoming years. Cardiovascular diseases, a type of health complication affecting the heart and blood vessels, account for a majority of global mortality, with three-quarters of CVD-related deaths taking place in low to middle-income countries. The use of direct oral anticoagulants, a form of anticoagulation medication therapy, is an effective technique to reduce the risk of thrombosis in numerous cardiovascular situations. To give an example, in May 2024, data from the US-based government agency, Centers for Disease Control and Prevention (CDC), stated that there had been 702,880 heart disease-related deaths in the United States in 2022. Out of these, coronary artery disease claimed 371,506 lives. Moreover, every year, around 805,000 individuals in the United States suffer a heart attack. Consequently, the rising instances of cardiovascular diseases fuel the expansion of the anticoagulants market.
What are the market segments in the anticoagulants industry?
The anticoagulants market covered in this report is segmented – _x000D_
_x000D_
1) By Drug Class: Factor Xa Inhibitor, Heparin And LMWH, Vitamin K Antagonist, Other Drug Classes_x000D_
2) By Route Of Administration: Oral Anticoagulant, Injectable Anticoagulant_x000D_
3) By Distribution Channel: Hospital Pharmacy, Retail Pharmacy, Online Pharmacy_x000D_
4) By Application: Venous Thromboembolism, Atrial Fibrillation Or Flutter, Coronary Artery Disease, Other Applications_x000D_
5) By End User: Hospitals, Homecare, Specialty Centers, Other End-Users_x000D_
_x000D_
Subsegments:_x000D_
1) By Factor Xa Inhibitor: Rivaroxaban, Apixaban, Edoxaban, Betrixaban_x000D_
2) By Heparin And LMWH (Low Molecular Weight Heparin): Unfractionated Heparin, Enoxaparin, Dalteparin, Tinzaparin_x000D_
3) By Vitamin K Antagonist: Warfarin, Acenocoumarol, Phenprocoumon_x000D_
4) By Other Drug Classes: Direct Thrombin Inhibitors, Antiplatelet Agents, Novel Oral Anticoagulants (NOACs)
Get your free sample now – explore exclusive market insights:
https://www.thebusinessresearchcompany.com/sample.aspx?id=5294&type=smp
Which leading companies are shaping the growth of the anticoagulants market?
Major companies operating in the anticoagulants market include GlaxoSmithKline plc, Leo Pharma A/S, Alexion Pharmaceuticals Inc., Amphastar Pharmaceuticals Inc., Bayer AG, Boehringer Ingelheim International GmbH, Daiichi Sankyo Company Limited, Eisai Co. Ltd., Mylan N. V., Otsuka Holdings Co. Ltd., Pfizer Inc., Sanofi S. A., Apotex Inc., Aspen Pharmacare Holdings Limited, AstraZeneca plc, Bristol-Myers Squibb Company, CSL Behring, Dr. Reddy’s Laboratories Ltd., Eli Lilly and Company, Fresenius Kabi AG, Hikma Pharmaceuticals plc, Johnson & Johnson, Lupin Limited, Mitsubishi Tanabe Pharma Corporation, Natco Pharma Limited, Novartis International AG, Portola Pharmaceuticals Inc., Strides Pharma Science Limited, Sun Pharmaceutical Industries Limited, Teva Pharmaceutical Industries Limited, Torrent Pharmaceuticals Limited, Zydus Cadila Healthcare Limited
What key trends are currently impacting the anticoagulants market’s development?
Leading firms in the anticoagulants market are concentrating on creating novel solutions such as factor Xa inhibitor tests to satisfy the surging need for testing, stemming from the escalated usage of direct oral anticoagulants for the prevention of strokes and other severe cardiovascular conditions. Factor Xa Inhibitor Tests are specially designed evaluations that measure the efficacy and safety of anticoagulant drugs which specifically inhibit factor Xa, thus preventing blood clot formation in several medical situations. For example, in February 2024, apixaban, edoxaban, and rivaroxaban coagulation tests were introduced by F. Hoffmann-La Roche Ltd., a biotech firm based in Switzerland. These newly introduced coagulation tests for Factor Xa inhibitors incorporate Roche’s advanced reagent cassette concept, ensuring excellent results and effective sample handling, while also promoting standardization and automation for improved laboratory workflow. These tests hold importance as they aid clinical decision-making in patients utilizing direct oral anticoagulants for stroke deterrence, meeting the growing worldwide demand for efficient diagnostics in managing critical conditions such as coronary artery disease and peripheral arterial disease.
Unlock exclusive market insights – purchase your research report now for a swift delivery!
https://www.thebusinessresearchcompany.com/purchaseoptions.aspx?id=5230
Which geographic areas are influencing the growth of the anticoagulants market?
North America was the largest region in the anticoagulants market in 2024. The regions covered in the anticoagulants market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa
Browse Through More Similar Reports By The Business Research Company:
Dialysis Devices And Equipment Global Market Report 2024
Hemodialysis And Peritoneal Dialysis Global Market Report 2024
Blood Glucose Meters Global Market Report 2024
https://www.thebusinessresearchcompany.com/report/blood-glucose-meters-global-market-report
About The Business Research Company:
With over 15000+ reports from 27 industries covering 60+ geographies, The Business Research Company has built a reputation for offering comprehensive, data-rich research and insights. Armed with 1,500,000 datasets, the optimistic contribution of in-depth secondary research, and unique insights from industry leaders, you can get the information you need to stay ahead in the game.
Contact us at:
The Business Research Company: https://www.thebusinessresearchcompany.com/
Americas +1 3156230293
Asia +44 2071930708
Europe +44 2071930708
Email us at [email protected]
Follow us on:
LinkedIn: https://in.linkedin.com/company/the-business-research-company
YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ
Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model
Found this article helpful? Share it on:
